technology .Exel is going to fly.More alliances and customers will be announce.Company getting higher visibility.They will have to split at some point in the future to increase liquidity and more institutional investors buying.This industry is so hot.This is my personal opinions.Do your own due diligence.
Can some one tell me, specifically...their one goal??? I own some of the stock but I still don't know exacly how will they generate revenue in the short and long term...and please don't tell me that cloning a few genes will make them rich. Thanx much
I am new on this board but as I understand they generate revenue short term from their big pharma collaborators through R&D funding and royalties. Their deal with Bayer only is worth $100 million+ in the next few years. Longer term they expect revenue from royalty payment and their own pipeline. Their business is in a favorable trjectory and I am long on the stock.